Feb 2, 2022 by Kody KesterViatris Hiked Its Dividend: Is It a Buy?The generic drug manufacturer recently rewarded shareholders with a massive dividend hike.
Feb 1, 2022 by Kody KesterIs This Small-Cap Medical Devices Stock a Buy?AngioDynamics managed to deliver solid revenue growth in the second quarter despite COVID-19 headwinds.
Jan 29, 2022 by Kody KesterIs This a Smart Deal for Pfizer?Pfizer and Biohaven recently completed a global commercialization deal worth up to $1.24 billion.
Jan 28, 2022 by Kody KesterCould Crown Castle Be a Millionaire-Maker REIT?Growing demand for wireless data is a major catalyst for the stock going forward.
Jan 27, 2022 by Kody KesterAmgen Wins Another Key Approval for This Potential Blockbuster Cancer DrugEarlier this month, the European Commission gave Lumykras the go-ahead as a treatment for lung cancer.
Jan 25, 2022 by Kody KesterGot $1,000? Here's 1 Great Stock to Buy and HoldAmid the economic reopening, the retail real estate investment trust Simon Property Group is thriving.
Jan 24, 2022 by Kody KesterWhat This FDA News Could Mean for AbbVie's StockAbbVie is hoping the FDA will green light Rinvoq to treat adults with a type of back arthritis.
Jan 21, 2022 by Kody Kester3 Undervalued Stocks You Can Buy TodayEach of these three stocks is priced at a discount based on its quality and growth prospects.
Jan 21, 2022 by Kody Kester3 Best Dividend Stocks That Wall Street Is Sleeping OnThese high-quality companies aren't getting the love that they deserve from investors.
Jan 20, 2022 by Kody Kester$300 a Month in These 3 Stocks Could Make You a Millionaire by RetirementThese three stocks have proven to be wonderful compounders, and there's little reason to believe that will change anytime soon.
Jan 20, 2022 by Kody KesterShould You Consider Buying This High-Yield Dividend Stock?The reasons to consider this stock go well beyond its 4% dividend yield and deflated share price.
Jan 20, 2022 by Kody KesterHere's What You Need to Know About Mastercard in 2022Upside in 2022 doesn't appear to be priced into the stock, but that may not last long.
Jan 18, 2022 by Kody KesterThis Stock Just Hiked Its Dividend; Is It a Buy?KeyCorp recently announced a 5.4% increase in its payout to shareholders. It reports earnings on Thursday.
Jan 18, 2022 by Kody KesterIs This Rapidly Growing Surgical Robotics Stock a Buy?Asensus Surgical's Senhance Surgical System is being more widely adopted by surgeons.
Jan 17, 2022 by Kody KesterThis Could Be Another Blockbuster Indication for AstraZenecaUltomiris could be just months away from its third approved indication in the U.S.
Jan 15, 2022 by Kody Kester3 Top Biotech Stocks to Buy Right NowEach of these companies possesses solid fundamentals and trades at reasonable valuations.
Jan 14, 2022 by Kody KesterMerck Snags Yet Another Indication for This Drug ComboThe company's blockbuster cancer drug Keytruda was approved in Japan to treat patients with certain types of endometrial cancer.
Jan 13, 2022 by Kody Kester3 Reasons to Buy This Newly Minted Dividend KingAbbott Laboratories recently joined the ranks of dividend payer royalty.
Jan 12, 2022 by Kody KesterShould You Buy W.P. Carey Stock?The diversified real estate investment trust is more than just its market-trouncing 5.3% dividend yield.
Jan 11, 2022 by Kody KesterHere's 1 High-Yield Dividend Stock You Can TrustMain Street Capital is arguably a best-of-breed business development company.
